ArticleScientific reports2025
Decision level scheme for fusing multiomics and histology slide images using deep neural network for tumor prognosis prediction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- MMBCFNet: multi modal hybrid deep learning framework for breast cancer detection using MRI, mammography, and ultrasound images.Journal of ultrasound · 2026Article
- A multimodal radiomics model to predict disease-free survival in resected non-small cell lung cancer: integrating clinicopathology, dual-energy CT, and deep learning features.Journal of thoracic disease · 2026Article
- Application of deep learning in prognostic prediction of non-small cell lung cancer.Frontiers in cell and developmental biology · 2026Review
- How gut microbiota contribute to neuropsychiatric disorders: evidence from neuroimaging studies.Frontiers in microbiology · 2026Review
- Artificial intelligence in multidisciplinary tumor boards enhancing decision making and clinical outcomes in oncology.iScience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Molecular biostatistical workflows in oncology often rely on predictive models that use multimodal data. Advances in deep learning and artificial intelligence technologies have enabled the multimodal fusion of large volumes of multimodal data. Here, we presented a decision level multimodal data fusion framework for integrating multiomics and pathological tissue slide images for prognosis prediction. Our approach established the spatial map of instances by connecting the neighboring nuclei in space and calculated the characteristic tensor via graph convolution layers for the input pathological tissue slide images. Global Average Pooling was applied to align and normalize the feature tensors from pathological images and the multiomics data, enabling seamless integration. We tested our proposed approach using Breast Invasive Carcinoma data and Non-Small Cell Lung Cancer data from the Cancer Genome Atlas, which contains paired whole-slide images, transcriptome data, genotype, epienetic, and survival information. In a 10-fold cross-validation, the comparison results demonstrated that the multimodal fusion paradigm improves outcome predictions from single modal data alone with the average C-index increasing from 0.61 to 0.52 to 0.75 and 0.67 for breast cancer and non-small cell lung cancer cohort, respectively. The proposed decision level multimodal data fusion framework is expected to provide insights and technical methodologies for the follow-up studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.